NCT06972355

Brief Summary

Objective: The aim of this study is to compare the efficiency of vision-obscured versus vision-retained treadmill gait training in subacute post-stroke patients. Methodology: Thirty-six patients with stroke (ischemic or hemorrhagic) less than six months old will be included and randomized into two parallel groups. The experimental group will undergo treadmill gait training using an opaque mask, combined with body weight reduction (Lite Gait® harness). The control group will follow the same walking protocol, but with their eyes open. Each session will last 20 minutes, integrated into one hour of rehabilitation, at a rate of three sessions per week for six weeks. Assessment will include single- and double-task walking speed, balance parameters and proprioception. Expected results: The hypothesis is that visual deprivation will stimulate the proprioceptive and vestibular systems to a greater extent, resulting in benefits for postural balance, walking and proprioception. The main hypothesis will be the improvement in the difference between single-task and double-task walking speed. Analyses will be conducted on an intention-to-treat basis, using statistical tests adapted to the nature of the variables. Conclusion: This study could highlight the value of temporary visual suppression as a therapeutic lever in stroke rehabilitation.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for not_applicable

Timeline
15mo left

Started Jun 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress44%
Jun 2025Jul 2027

First Submitted

Initial submission to the registry

April 25, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

May 15, 2025

Completed
20 days until next milestone

Study Start

First participant enrolled

June 4, 2025

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 19, 2027

Last Updated

October 1, 2025

Status Verified

September 1, 2025

Enrollment Period

2 years

First QC Date

April 25, 2025

Last Update Submit

September 30, 2025

Conditions

Keywords

StrokeGaitTreadmillDouble taskProprioceptionPostural balance

Outcome Measures

Primary Outcomes (1)

  • Dual-task walking speed assessment

    Speed (m/s) The dual-task walking speed assessment measures how well a person walks while simultaneously performing a cognitive or motor task. It helps identify changes in gait speed and stability when attention is divided, revealing potential fall risk or cognitive-motor interference.

    6 weeks after subacute stroke

Secondary Outcomes (9)

  • Gait Speed assessment

    3 to 6 monts after subacute stroke

  • Average step duration evaluation

    3 to 6 monts after subacute stroke

  • Gait symmetry evaluation

    3 to 6 monts after subacute stroke

  • Cycle duration variability evaluation

    3 to 6 monts after subacute stroke

  • Single-task and double-task gait speed evaluation

    3 to 6 monts after subacute stroke

  • +4 more secondary outcomes

Study Arms (2)

Hidden Eyes

EXPERIMENTAL

Treadmill walking training with body weight reduced and eyes hidden

Procedure: Hiding the eyes

Open Eyes

NO INTERVENTION

Treadmill walking training with reduced body weight and open eyes.

Interventions

Patients will participate in walking rehabilitation sessions on a treadmill supported by a Lite Gait® harness. All treadmill sessions are consistent with regular rehabilitation sessions. A typical treadmill walking session will take place 3 times a week for 6 weeks, lasting 20 minutes. During the first minute, the speed of the treadmill is gradually increased until a comfortable speed is reached. From then on, the mask will be placed over the patient's eyes for 18 minutes at a constant, i.e. comfortable, speed. The last minute will be devoted to gradually decreasing the treadmill speed until it stops, and will also be performed without the mask.

Hidden Eyes

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years of age or older,
  • With a confirmed diagnosis of ischemic or hemorrhagic stroke in sub-acute phase (stroke less than 6 months old),
  • With NIHSS scores between 1 and 15 and MoCA scores between 18 and 30
  • With a physiotherapy prescription for post Stroke rehabilitation
  • Able to walk for 20 min on a treadmill with weight reduction with pauses, able to maintain bipodal balance, able to maintain bipodal balance with eyes open and closed for 30 seconds,
  • Having expressed free, informed and written consent
  • Affiliated with a social security scheme.

You may not qualify if:

  • Patients weighing over 200 kg (maximum weight permitted for use of the Lite Gait ®),
  • Patients with impaired vision:
  • Best corrected visual acuity below 5/10 on patient examination
  • Homonymous lateral hemianopia, quadranopia.
  • Inability to physically participate in intensive rehabilitation due to severe, unstabilized and comorbidities (heart, lung, kidney disease or diabetes), severe psychiatric disorders cancer active or under treatment.
  • Patients participating in other interventional research,
  • Pregnant or breast-feeding women,
  • Patients under guardianship.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHR Metz-Thionville Hopital Legouest

Metz, 57085, France

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Pauline AMSTUTZ

    CHR Metz Thionville Hopital Legouest

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 25, 2025

First Posted

May 15, 2025

Study Start

June 4, 2025

Primary Completion (Estimated)

June 4, 2027

Study Completion (Estimated)

July 19, 2027

Last Updated

October 1, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

Locations